Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

1.

Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen.

Muss HB, Bunn JY, Crocker A, Plaut K, Koh J, Heintz N, Rincon M, Weaver DL, Tam D, Beatty B, Kaufman P, Donovan M, Verbel D, Weiss L.

Breast J. 2007 Jul-Aug;13(4):337-45.

PMID:
17593037
[PubMed - indexed for MEDLINE]
2.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
3.

Factors predictive of response to hormone therapy in breast cancer.

Rastelli F, Crispino S.

Tumori. 2008 May-Jun;94(3):370-83. Review.

PMID:
18705406
[PubMed - indexed for MEDLINE]
4.

Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.

Ciocca DR, Gago FE, Fanelli MA, Calderwood SK.

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):32-40. Epub 2006 Oct 17. Review.

PMID:
17049840
[PubMed - indexed for MEDLINE]
5.

Reducing the risk of late recurrence in hormone-responsive breast cancer.

Cufer T.

Ann Oncol. 2007 Sep;18 Suppl 8:viii18-25. Review.

PMID:
17890210
[PubMed - indexed for MEDLINE]
Free Article
6.

Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.

Gee JM, Robertson JF, Gutteridge E, Ellis IO, Pinder SE, Rubini M, Nicholson RI.

Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S99-S111. Review.

PMID:
16113104
[PubMed - indexed for MEDLINE]
Free Article
7.

Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.

Jahanzeb M.

Clin Ther. 2007 Aug;29(8):1535-47. Review.

PMID:
17919537
[PubMed - indexed for MEDLINE]
8.

Selecting endocrine therapy for breast cancer: what role does HER-2/neu status play?

Prowell TM, Armstrong DK.

Semin Oncol. 2006 Dec;33(6):681-7. Review.

PMID:
17145348
[PubMed - indexed for MEDLINE]
9.

The role of endocrine therapies in reducing risk of recurrence in postmenopausal women with hormone receptor-positive breast cancer.

Pennery E.

Eur J Oncol Nurs. 2008 Jul;12(3):233-43. doi: 10.1016/j.ejon.2008.01.007. Epub 2008 Mar 26. Review.

PMID:
18372213
[PubMed - indexed for MEDLINE]
10.

Molecular markers for predicting response to tamoxifen in breast cancer patients.

Ciocca DR, Elledge R.

Endocrine. 2000 Aug;13(1):1-10. Review.

PMID:
11051041
[PubMed - indexed for MEDLINE]
11.

What clinicians need to know about antioestrogen resistance in breast cancer therapy.

Milano A, Dal Lago L, Sotiriou C, Piccart M, Cardoso F.

Eur J Cancer. 2006 Nov;42(16):2692-705. Epub 2006 Sep 11. Review.

PMID:
16963260
[PubMed - indexed for MEDLINE]
12.

Reliability of estrogen receptors in predicting response to antiestrogens.

Valavaara R.

Oncology (Williston Park). 1997 May;11(5 Suppl 4):14-8. Review.

PMID:
9165501
[PubMed - indexed for MEDLINE]
13.

Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma.

Jabbour MN, Massad CY, Boulos FI.

Breast Cancer Res Treat. 2012 Aug;135(1):29-37. doi: 10.1007/s10549-012-2047-z. Epub 2012 Apr 8. Review.

PMID:
22484731
[PubMed - indexed for MEDLINE]
14.

Predictors of response to systemic therapy in breast cancer.

Ring AE, Ellis PA.

Forum (Genova). 2002;12(1):19-32. Review.

PMID:
12634908
[PubMed - indexed for MEDLINE]
15.

Steroid hormone receptors and antineoplastic chemotherapy in human breast cancer.

Görlich M, Jandrig B.

J Exp Clin Cancer Res. 1997 Mar;16(1):95-103. Review.

PMID:
9148869
[PubMed - indexed for MEDLINE]
16.

The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I, Ben-Baruch A.

Clin Cancer Res. 2006 Aug 1;12(15):4474-80. Review.

PMID:
16899591
[PubMed - indexed for MEDLINE]
Free Article
17.

Biomolecular markers of breast cancer.

Nicolini A, Carpi A, Tarro G.

Front Biosci. 2006 May 1;11:1818-43. Review.

PMID:
16368559
[PubMed - indexed for MEDLINE]
18.

Prognostic and predictive factors in breast cancer.

Bundred NJ.

Cancer Treat Rev. 2001 Jun;27(3):137-42. Review.

PMID:
11417963
[PubMed - indexed for MEDLINE]
19.

HER2. a 'predictive factor' ready to use in the daily management of breast cancer patients?

Piccart MJ, Di Leo A, Hamilton A.

Eur J Cancer. 2000 Sep;36(14):1755-61. Review.

PMID:
10974622
[PubMed - indexed for MEDLINE]
20.

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Allred DC, Harvey JM, Berardo M, Clark GM.

Mod Pathol. 1998 Feb;11(2):155-68. Review.

PMID:
9504686
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk